Literature DB >> 22668953

Advances in childhood tuberculosis - contributions from the University of Cape Town.

Heather J Zar1, Brian Eley, Mark P Nicol, Anthony Figaji, Anthony Hawkridge.   

Abstract

UNLABELLED: Childhood tuberculosis (TB) is common in high TB burden countries, contributing a substantial proportion to the TB caseload. The HIV epidemic has had a large impact on the incidence, diagnosis and management of childhood TB. AIM: To review the contributions from researchers at the University of Cape Town to the field of childhood TB over the past decades.
METHODS: Review of published literature on studies of childhood TB done by investigators from the University of Cape Town.
RESULTS: Important advances have been made, especially in the areas of epidemiology, diagnosis and prevention of childhood TB. Epidemiological research has led to improved understanding of the large burden of childhood TB in Cape Town. Advances in diagnosis include use of improved specimens, particularly induced sputum and better diagnostic tests. The efficacy of GeneXpert, a rapid polymerase chain reaction (PCR)-based diagnostic test, on induced sputum specimens, has potential to enable a confirmed diagnosis in children of all ages at a range of healthcare facilities, and represents an important advance in management of children presenting with suspected TB. Advances in prevention include the establishment of a vaccine study site and several studies on immunisation, and on the use of primary isoniazid prophylaxis as an effective preventive strategy in symptomatic HIV-infected children.
CONCLUSION: Research in childhood TB has led to important advances in diagnosis and management, enabling better care for HIV-infected and uninfected children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22668953     DOI: 10.7196/samj.5552

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants.

Authors:  M Tameris; D A Hokey; V Nduba; J Sacarlal; F Laher; G Kiringa; K Gondo; E M Lazarus; G E Gray; S Nachman; H Mahomed; K Downing; B Abel; T J Scriba; J B McClain; M G Pau; J Hendriks; V Dheenadhayalan; S Ishmukhamedov; A K K Luabeya; H Geldenhuys; B Shepherd; G Blatner; V Cardenas; R Walker; W A Hanekom; J Sadoff; M Douoguih; L Barker; M Hatherill
Journal:  Vaccine       Date:  2015-04-28       Impact factor: 3.641

2.  Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.

Authors:  B Zeldow; S Kim; G McSherry; M F Cotton; P Jean-Philippe; A Violari; R Bobat; S Nachman; L M Mofenson; S A Madhi; C Mitchell
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

3.  Assessment of airway compression on chest radiographs in children with pulmonary tuberculosis.

Authors:  Lisel Richter-Joubert; Savvas Andronikou; Lesley Workman; Heather J Zar
Journal:  Pediatr Radiol       Date:  2017-05-29

4.  Diagnostic accuracy of microscopic Observation Drug Susceptibility (MODS) assay for pediatric tuberculosis in Hanoi, Vietnam.

Authors:  Sinh Thi Tran; John Patrick Renschler; Hai Thanh Le; Hang Thi Thu Dang; Tuan Minh Dao; An Nhat Pham; Liem Thanh Nguyen; Hung Van Nguyen; Thuy Thi Thu Nguyen; Sy Ngoc Le; Annette Fox; Maxine Caws; Nhu Thi Quynh Nguyen; Nhudo Thi Quynh; Peter Horby; Heiman Wertheim
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.